nifedipine has been researched along with oxyphenbutazone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Duan, YC; Guan, YY; Yu, T; Zhang, SJ; Zhang, YZ; Zhao, F; Zhao, Y; Zhou, XL | 1 |
| Chen, KX; Ding, H; Du, DH; Hu, JC; Jiang, HL; Kong, XQ; Li, LC; Liu, JQ; Luo, C; Zhu, MR | 1 |
1 review(s) available for nifedipine and oxyphenbutazone
| Article | Year |
|---|---|
Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.
Topics: Ectoderm; Enhancer of Zeste Homolog 2 Protein; Humans; Intercellular Signaling Peptides and Proteins; Neoplasms; Polycomb Repressive Complex 2 | 2022 |
4 other study(ies) available for nifedipine and oxyphenbutazone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Development of a high-throughput fluorescence polarization assay for the discovery of EZH2-EED interaction inhibitors.
Topics: Apomorphine; Enhancer of Zeste Homolog 2 Protein; Ergonovine; Fluorescence Polarization; High-Throughput Screening Assays; Humans; Hydrogen-Ion Concentration; Limit of Detection; Nifedipine; Oxyphenbutazone; Peptide Fragments; Polycomb Repressive Complex 2; Protein Binding; Protein Multimerization; Temperature | 2018 |